A shared formulation design space reveals poly(2-ethyl-2oxazoline) chain length as a determinant of lipid nanoparticle performance and relative organ distribution
The interface between lipid nanoparticles (LNPs) and their biological environment represents a key determinant of biodistribution. Here, we investigated poly(2-ethyl-2oxazoline) (PEtOx)-lipids as an adaptable component of this interface and determined how polymer chain length affects LNP formulation as well as biological behavior. Rather than comparing different polymers with a single nominal formulation composition, we first mapped the pharmaceutical design space of four PEtOx-lipids containing average chain lengths of 20, 34, 49, or 71 repeating units and identified formulation conditions that supported acceptable LNP formation. This shared design space subsequently enabled the comparison of chain-length-dependent effects under pharmaceutically viable conditions. Increasing PEtOx chain length decreased the apparent hydrophobicity of the PEtOx-lipids and was associated with progressively smaller LNP diameters, lower mRNA encapsulation efficiencies, and a narrower formulation space in which predefined criteria for size, polydispersity, and mRNA loading were met concomitantly. Optimized PEtOx-LNPs mediated mRNA expression across multiple primary and human induced pluripotent stem cell-derived cell types with limited effects on cell viability. Pooled in vivo DNA barcoding of the PEtOx20-, PEtOx34-, and PEtOx49-LNPs revealed chain-length-dependent differences in relative organ barcode distribution, with shorter chains shifting relative distribution toward spleen and pancreas and away from bone marrow and liver. Together, these findings establish PEtOx chain length as an independent LNP design parameter and demonstrate a formulation-space-based strategy for comparing polymeric excipients without relying on a single predefined formulation composition.
Authors
- Tessa C. Lühmann (ORCID: https://orcid.org/0000-0001-7552-6435)
- Lorenz Meinel (ORCID: https://orcid.org/0000-0002-7549-7627)
- Ekaterina Tsarenko (ORCID: https://orcid.org/0009-0002-0663-3776)
- Ilayda Ates (ORCID: https://orcid.org/0009-0005-8405-4413)
- Josef Kehrein (ORCID: https://orcid.org/0000-0003-4042-6762)
- Marcus Gutmann (ORCID: https://orcid.org/0000-0001-6000-7923)
- Xiaoxuan Wang (ORCID: https://orcid.org/0009-0000-4239-574X)
- Hans‐Peter Holthoff (ORCID: https://orcid.org/0000-0001-6403-7759)
- Sarah Heil
- Barbara Fink
- Julia Klüpfel (ORCID: https://orcid.org/0000-0003-0226-4256)
- Tim Ammon (ORCID: https://orcid.org/0009-0002-3561-6094)
- Caroline T. Holick (ORCID: https://orcid.org/0009-0000-1724-2725)
- Stephanie M. Schubert (ORCID: https://orcid.org/0000-0001-9527-7763)
- Ulrich S. Schubert (ORCID: https://orcid.org/0000-0003-4978-4670)
- Ivo Nischang (ORCID: https://orcid.org/0000-0001-6182-5215)
- Martin J. Lohse (ORCID: https://orcid.org/0000-0002-0599-3510)
- Christine Weber (ORCID: https://orcid.org/0000-0003-0712-5255)
- Lília Espada (ORCID: https://orcid.org/0000-0002-6218-7785)
- Florian A. Mann (ORCID: https://orcid.org/0000-0003-2348-1663)
- Martin Ungerer (ORCID: https://orcid.org/0000-0002-5198-3399)
- Manuela Benedicic
- Franziska Adermann (ORCID: https://orcid.org/0009-0003-4012-7567)
- Markus Hafke
- Miriam A. Christlmeier (ORCID: https://orcid.org/0009-0000-6571-6745)
- Giorgia Gerolimetto (ORCID: https://orcid.org/0009-0008-9170-1414)
- Felix Schuster
- Susanne Götze
- Emma Steffens
Institutions
- Helmholtz Institute Jena (DE)
- University of Würzburg (DE)
- Helmholtz-Zentrum Berlin für Materialien und Energie (DE)
- Helmholtz Institute for RNA-based Infection Research (DE)
- Technical University of Munich (DE)
- Bayer (Germany) (DE)
- Friedrich Schiller University Jena (DE)
Publication Details
- Journal
- ChemRxiv
- Published
- 2026-11-17
- DOI
- https://doi.org/10.26434/chemrxiv.15012355/v1
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- preprint